GLOBAL CANCER TREATMENT DRUGS MARKET 2024 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2030

Jan 2024 155
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cancer Treatment Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy
1.3.5 Hormonal Therapy (Biologic Therapy)
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cancer Treatment Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory or Lung Cancer
1.4.7 Others
1.5 Global Cancer Treatment Drugs Market Size & Forecast
1.5.1 Global Cancer Treatment Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cancer Treatment Drugs Sales Quantity (2019-2030)
1.5.3 Global Cancer Treatment Drugs Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cancer Treatment Drugs Product and Services
2.1.4 Roche Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cancer Treatment Drugs Product and Services
2.2.4 Novartis Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Treatment Drugs Product and Services
2.3.4 Celgene Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Product and Services
2.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Cancer Treatment Drugs Product and Services
2.5.4 Amgen Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Amgen Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Cancer Treatment Drugs Product and Services
2.6.4 Johnson & Johnson Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Cancer Treatment Drugs Product and Services
2.7.4 Pfizer Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments/Updates
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Cancer Treatment Drugs Product and Services
2.8.4 Takeda Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Takeda Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Cancer Treatment Drugs Product and Services
2.9.4 Eli Lilly Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Cancer Treatment Drugs Product and Services
2.10.4 AstraZeneca Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Cancer Treatment Drugs Product and Services
2.11.4 Astellas Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Astellas Recent Developments/Updates
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Cancer Treatment Drugs Product and Services
2.12.4 Merck & Co. Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck & Co. Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Cancer Treatment Drugs Product and Services
2.13.4 Sanofi Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sanofi Recent Developments/Updates
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Cancer Treatment Drugs Product and Services
2.14.4 Bayer Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bayer Recent Developments/Updates
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Cancer Treatment Drugs Product and Services
2.15.4 Biogen Idec Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Biogen Idec Recent Developments/Updates
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Cancer Treatment Drugs Product and Services
2.16.4 Eisai Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Eisai Recent Developments/Updates
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Cancer Treatment Drugs Product and Services
2.17.4 Teva Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Teva Recent Developments/Updates
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Cancer Treatment Drugs Product and Services
2.18.4 Otsuka Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Otsuka Recent Developments/Updates
2.19 Merck KGaA
2.19.1 Merck KGaA Details
2.19.2 Merck KGaA Major Business
2.19.3 Merck KGaA Cancer Treatment Drugs Product and Services
2.19.4 Merck KGaA Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Merck KGaA Recent Developments/Updates
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Cancer Treatment Drugs Product and Services
2.20.4 Ipsen Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Ipsen Recent Developments/Updates
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business
2.21.3 AbbVie Cancer Treatment Drugs Product and Services
2.21.4 AbbVie Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 AbbVie Recent Developments/Updates
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Cancer Treatment Drugs Product and Services
2.22.4 Gilead Sciences Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Gilead Sciences Recent Developments/Updates
3 Competitive Environment: Cancer Treatment Drugs by Manufacturer
3.1 Global Cancer Treatment Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cancer Treatment Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Cancer Treatment Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Cancer Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share in 2023
3.5 Cancer Treatment Drugs Market: Overall Company Footprint Analysis
3.5.1 Cancer Treatment Drugs Market: Region Footprint
3.5.2 Cancer Treatment Drugs Market: Company Product Type Footprint
3.5.3 Cancer Treatment Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cancer Treatment Drugs Market Size by Region
4.1.1 Global Cancer Treatment Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Cancer Treatment Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Cancer Treatment Drugs Average Price by Region (2019-2030)
4.2 North America Cancer Treatment Drugs Consumption Value (2019-2030)
4.3 Europe Cancer Treatment Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Cancer Treatment Drugs Consumption Value (2019-2030)
4.5 South America Cancer Treatment Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Cancer Treatment Drugs Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Cancer Treatment Drugs Sales Quantity by Type (2019-2030)
5.2 Global Cancer Treatment Drugs Consumption Value by Type (2019-2030)
5.3 Global Cancer Treatment Drugs Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Cancer Treatment Drugs Sales Quantity by Application (2019-2030)
6.2 Global Cancer Treatment Drugs Consumption Value by Application (2019-2030)
6.3 Global Cancer Treatment Drugs Average Price by Application (2019-2030)
7 North America
7.1 North America Cancer Treatment Drugs Sales Quantity by Type (2019-2030)
7.2 North America Cancer Treatment Drugs Sales Quantity by Application (2019-2030)
7.3 North America Cancer Treatment Drugs Market Size by Country
7.3.1 North America Cancer Treatment Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Cancer Treatment Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Cancer Treatment Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Cancer Treatment Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Cancer Treatment Drugs Market Size by Country
8.3.1 Europe Cancer Treatment Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Cancer Treatment Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Cancer Treatment Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cancer Treatment Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cancer Treatment Drugs Market Size by Region
9.3.1 Asia-Pacific Cancer Treatment Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cancer Treatment Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Cancer Treatment Drugs Sales Quantity by Type (2019-2030)
10.2 South America Cancer Treatment Drugs Sales Quantity by Application (2019-2030)
10.3 South America Cancer Treatment Drugs Market Size by Country
10.3.1 South America Cancer Treatment Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Cancer Treatment Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Cancer Treatment Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cancer Treatment Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cancer Treatment Drugs Market Size by Country
11.3.1 Middle East & Africa Cancer Treatment Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cancer Treatment Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Cancer Treatment Drugs Market Drivers
12.2 Cancer Treatment Drugs Market Restraints
12.3 Cancer Treatment Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Cancer Treatment Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cancer Treatment Drugs
13.3 Cancer Treatment Drugs Production Process
13.4 Cancer Treatment Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cancer Treatment Drugs Typical Distributors
14.3 Cancer Treatment Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Cancer Treatment Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cancer Treatment Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Cancer Treatment Drugs Product and Services
Table 6. Roche Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Cancer Treatment Drugs Product and Services
Table 11. Novartis Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Celgene Basic Information, Manufacturing Base and Competitors
Table 14. Celgene Major Business
Table 15. Celgene Cancer Treatment Drugs Product and Services
Table 16. Celgene Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Celgene Recent Developments/Updates
Table 18. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Cancer Treatment Drugs Product and Services
Table 21. Bristol-Myers Squibb Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bristol-Myers Squibb Recent Developments/Updates
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Cancer Treatment Drugs Product and Services
Table 26. Amgen Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Amgen Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Cancer Treatment Drugs Product and Services
Table 31. Johnson & Johnson Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Cancer Treatment Drugs Product and Services
Table 36. Pfizer Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Pfizer Recent Developments/Updates
Table 38. Takeda Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Major Business
Table 40. Takeda Cancer Treatment Drugs Product and Services
Table 41. Takeda Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Takeda Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Cancer Treatment Drugs Product and Services
Table 46. Eli Lilly Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 49. AstraZeneca Major Business
Table 50. AstraZeneca Cancer Treatment Drugs Product and Services
Table 51. AstraZeneca Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Astellas Basic Information, Manufacturing Base and Competitors
Table 54. Astellas Major Business
Table 55. Astellas Cancer Treatment Drugs Product and Services
Table 56. Astellas Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Astellas Recent Developments/Updates
Table 58. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 59. Merck & Co. Major Business
Table 60. Merck & Co. Cancer Treatment Drugs Product and Services
Table 61. Merck & Co. Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Merck & Co. Recent Developments/Updates
Table 63. Sanofi Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi Major Business
Table 65. Sanofi Cancer Treatment Drugs Product and Services
Table 66. Sanofi Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sanofi Recent Developments/Updates
Table 68. Bayer Basic Information, Manufacturing Base and Competitors
Table 69. Bayer Major Business
Table 70. Bayer Cancer Treatment Drugs Product and Services
Table 71. Bayer Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Bayer Recent Developments/Updates
Table 73. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 74. Biogen Idec Major Business
Table 75. Biogen Idec Cancer Treatment Drugs Product and Services
Table 76. Biogen Idec Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Biogen Idec Recent Developments/Updates
Table 78. Eisai Basic Information, Manufacturing Base and Competitors
Table 79. Eisai Major Business
Table 80. Eisai Cancer Treatment Drugs Product and Services
Table 81. Eisai Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Eisai Recent Developments/Updates
Table 83. Teva Basic Information, Manufacturing Base and Competitors
Table 84. Teva Major Business
Table 85. Teva Cancer Treatment Drugs Product and Services
Table 86. Teva Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Teva Recent Developments/Updates
Table 88. Otsuka Basic Information, Manufacturing Base and Competitors
Table 89. Otsuka Major Business
Table 90. Otsuka Cancer Treatment Drugs Product and Services
Table 91. Otsuka Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Otsuka Recent Developments/Updates
Table 93. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 94. Merck KGaA Major Business
Table 95. Merck KGaA Cancer Treatment Drugs Product and Services
Table 96. Merck KGaA Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Merck KGaA Recent Developments/Updates
Table 98. Ipsen Basic Information, Manufacturing Base and Competitors
Table 99. Ipsen Major Business
Table 100. Ipsen Cancer Treatment Drugs Product and Services
Table 101. Ipsen Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Ipsen Recent Developments/Updates
Table 103. AbbVie Basic Information, Manufacturing Base and Competitors
Table 104. AbbVie Major Business
Table 105. AbbVie Cancer Treatment Drugs Product and Services
Table 106. AbbVie Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. AbbVie Recent Developments/Updates
Table 108. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 109. Gilead Sciences Major Business
Table 110. Gilead Sciences Cancer Treatment Drugs Product and Services
Table 111. Gilead Sciences Cancer Treatment Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Gilead Sciences Recent Developments/Updates
Table 113. Global Cancer Treatment Drugs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 114. Global Cancer Treatment Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 115. Global Cancer Treatment Drugs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 116. Market Position of Manufacturers in Cancer Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 117. Head Office and Cancer Treatment Drugs Production Site of Key Manufacturer
Table 118. Cancer Treatment Drugs Market: Company Product Type Footprint
Table 119. Cancer Treatment Drugs Market: Company Product Application Footprint
Table 120. Cancer Treatment Drugs New Market Entrants and Barriers to Market Entry
Table 121. Cancer Treatment Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Cancer Treatment Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 123. Global Cancer Treatment Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 124. Global Cancer Treatment Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 125. Global Cancer Treatment Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 126. Global Cancer Treatment Drugs Average Price by Region (2019-2024) & (USD/Pcs)
Table 127. Global Cancer Treatment Drugs Average Price by Region (2025-2030) & (USD/Pcs)
Table 128. Global Cancer Treatment Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 129. Global Cancer Treatment Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 130. Global Cancer Treatment Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Global Cancer Treatment Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Global Cancer Treatment Drugs Average Price by Type (2019-2024) & (USD/Pcs)
Table 133. Global Cancer Treatment Drugs Average Price by Type (2025-2030) & (USD/Pcs)
Table 134. Global Cancer Treatment Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 135. Global Cancer Treatment Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 136. Global Cancer Treatment Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 137. Global Cancer Treatment Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 138. Global Cancer Treatment Drugs Average Price by Application (2019-2024) & (USD/Pcs)
Table 139. Global Cancer Treatment Drugs Average Price by Application (2025-2030) & (USD/Pcs)
Table 140. North America Cancer Treatment Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 141. North America Cancer Treatment Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 142. North America Cancer Treatment Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 143. North America Cancer Treatment Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 144. North America Cancer Treatment Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 145. North America Cancer Treatment Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 146. North America Cancer Treatment Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 147. North America Cancer Treatment Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Europe Cancer Treatment Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 149. Europe Cancer Treatment Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 150. Europe Cancer Treatment Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 151. Europe Cancer Treatment Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 152. Europe Cancer Treatment Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 153. Europe Cancer Treatment Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 154. Europe Cancer Treatment Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe Cancer Treatment Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific Cancer Treatment Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 157. Asia-Pacific Cancer Treatment Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 158. Asia-Pacific Cancer Treatment Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 159. Asia-Pacific Cancer Treatment Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 160. Asia-Pacific Cancer Treatment Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 161. Asia-Pacific Cancer Treatment Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 162. Asia-Pacific Cancer Treatment Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 163. Asia-Pacific Cancer Treatment Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 164. South America Cancer Treatment Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 165. South America Cancer Treatment Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 166. South America Cancer Treatment Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 167. South America Cancer Treatment Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 168. South America Cancer Treatment Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 169. South America Cancer Treatment Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 170. South America Cancer Treatment Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 171. South America Cancer Treatment Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 172. Middle East & Africa Cancer Treatment Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 173. Middle East & Africa Cancer Treatment Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 174. Middle East & Africa Cancer Treatment Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 175. Middle East & Africa Cancer Treatment Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 176. Middle East & Africa Cancer Treatment Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 177. Middle East & Africa Cancer Treatment Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 178. Middle East & Africa Cancer Treatment Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 179. Middle East & Africa Cancer Treatment Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 180. Cancer Treatment Drugs Raw Material
Table 181. Key Manufacturers of Cancer Treatment Drugs Raw Materials
Table 182. Cancer Treatment Drugs Typical Distributors
Table 183. Cancer Treatment Drugs Typical Customers
List of Figures
Figure 1. Cancer Treatment Drugs Picture
Figure 2. Global Cancer Treatment Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cancer Treatment Drugs Consumption Value Market Share by Type in 2023
Figure 4. Chemotherapy Examples
Figure 5. Targeted Therapy Examples
Figure 6. Immunotherapy Examples
Figure 7. Hormonal Therapy (Biologic Therapy) Examples
Figure 8. Others Examples
Figure 9. Global Cancer Treatment Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Cancer Treatment Drugs Consumption Value Market Share by Application in 2023
Figure 11. Blood Cancer Examples
Figure 12. Breast Cancer Examples
Figure 13. Gastrointestinal Cancer Examples
Figure 14. Prostate Cancer Examples
Figure 15. Respiratory or Lung Cancer Examples
Figure 16. Others Examples
Figure 17. Global Cancer Treatment Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Cancer Treatment Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Cancer Treatment Drugs Sales Quantity (2019-2030) & (K Pcs)
Figure 20. Global Cancer Treatment Drugs Average Price (201

Table of Contents

Related reports :

(Jan 24)

According to our (Global Info Research) latest study, the global Deferiprone market size was valued at USD 37 million in 2023 and is forecas...

(Jan 24)

According to our (Global Info Research) latest study, the global Deferasirox market size was valued at USD 2808.8 million in 2023 and is for...

(Jan 24)

According to our (Global Info Research) latest study, the global Biopharmaceutical Logistic market size was valued at USD 88220 million in 2...

(Jan 24)

According to our (Global Info Research) latest study, the global Legal Marijuana market size was valued at USD 28400 million in 2023 and is ...

(Jan 24)

According to our (Global Info Research) latest study, the global Vaccine Adjuvants market size was valued at USD 877.5 million in 2023 and i...

(Jan 24)

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 an...

Global Info Research

GLOBAL CANCER TREATMENT DRUGS MARKET 2024 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2030

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy